6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
12m ago	Commerzbank AG (London Branch) - Post Stabilisation Notice
13m ago	Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
13m ago	PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026
14m ago	AM Best Affirms Credit Ratings of Ping An Property & Casualty Insurance Company of China, Ltd
15m ago	Michelin: Annual Shareholders Meeting of May 22, 2026

About

435.94USD+2.40 +0.55%

Closed • Updated at 14:48 GMT+00:00

Market Cap$110.64B

P/E Ratio25.84

Volume180.4K

Beta0.23

RSI49.20

Gross Margin86.38%

Health TechnologyPharmaceuticals: Major

Vertex Pharmaceuticals Incorporated — investor relations, events, news, and company updates on 6ix.

Latest News

Vertex Announces New Drug Submission for Suzetrigine Has Been Accepted for Review by Health Canada for the Treatment of Moderate-to-Severe Acute Pain in Adults

Vertex to Participate in Upcoming May Investor Conferences

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

Vertex Reports First Quarter 2026 Financial Results

Vortex Energy Announces Intent to Advance Next Phase of Technical Work at the Robinsons River Salt Project and Engages Lonquist

Community Chat

Ask AI